Merit Medical Systems Inc., a manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology, and endoscopy, announces that the U.S. Food and Drug Administration(FDA) has completed its evaluation of Merit's corrective actions in response to a warning letter issued to the company in January, related to the Merit Laureate(R) Hydrophilic Guidewire. The FDA sent a letter to Merit Medical this week stating that it appears Merit has addressed the violation contained in the warning letter.
Latest from Today's Medical Developments
- Boston Scientific to acquire Penumbra, expanding cardiovascular portfolio
- Star Cutter introduces Double Pilot Reamer
- #80 Manufacturing Matters - Machining Strategies to Save Time and Improve your Process for MedTech Components with Kennametal Inc.
- Real-world parts and expert manufacturing advice
- Experts discuss the latest in toolholding technology
- How permanent magnets are powering medical innovation
- Forecasting the year ahead in design and manufacturing
- Tecomet, Orchid Orthopedic Solutions announce merger agreement